Analysis of the influence of drug resistance factors on the efficacy of combinations of antibiotics for multidrug-resistant Pseudomonas aeruginosa isolated from hospitals located in the suburbs of Kanto area, Japan

Journal of Global Antimicrobial Resistance

Volumn 1, Issue 2, 2013, Pages 91-96

  Kataoka, Hiroshi ^a   Ida, Takashi ^a   Ishii, Yoshikazu ^b   Tateda, Kazuhiro ^b   Oguri, Toyoko ^c   Yoshida, Atsushi ^d   Okuzumi, Katsuko ^d   Oishi, Tsuyoshi ^e   Tsukahara, Miyuki ^e   Mori, Shin Ichiro ^f   Yoneyama, Akiko ^g   Araoka, Hideki ^g   Mitsuda, Toshihiro ^h   Sumitomo, Midori ^h   Moriya, Kyoji ⁱ   Goto, Mieko ⁱ   Nakamori, Yoshitaka ^j   Shibayama, Akiyoshi ^j   Ohmagari, Norio ^k   Sato, Tomoaki ^k   Yamaguchi, Keizo ^b   more..

^a MEIJI SEIKA KAISHA LTD   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Kameda General Hospital   (Japan)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

^e TOKYO MEDICAL UNIVERSITY   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL   (Japan)

^g TORANOMON HOSPITAL   (Japan)

^h YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

ⁱ UNIVERSITY OF TOKYO   (Japan)

^j Misyuku Hospital   (Japan)

^k SHIZUOKA CANCER CENTER   (Japan)

more..

Author keywords

Aeruginosa; Combination effect; Multidrug resistant Pseudomonas; Resistance factor

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; HABEKACIN; IMIPENEM; MEROPENEM; PIPERACILLIN; RIFAMPICIN; TOBRAMYCIN;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; HOSPITAL; JAPAN; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; R FACTOR;

EID: 84893099608     PISSN: 22137165     EISSN: 22137173     Source Type: Journal    
DOI: 10.1016/j.jgar.2013.03.005     Document Type: Article

References (22)

1. MesarosN,Nordmann P, Plesiat P, Roussel-DelvallezM,Van Eldere J, Glupczynski Y, et al. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clinical Microbiology and Infection 2007;13:560-78.
2. Kirikae T, Mizuguchi Y, Arakawa Y. Investigation of isolation rates of Pseudomonas aeruginosa with and without multidrug resistance in medical facilities and clinical laboratories in Japan. Journal of Antimicrobial Chemotherapy 2008;61:612-5.
3. Aoki N, Tateda K, Kikuchi Y, Kimura S, Miyazaki C, Ishii Y, et al. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 2009;63:534-42.
4. Erdem I, Kucukercan M, Ceran N. In vitro activity of combination therapy with cefepime, piperacillin-tazobactam, or meropenem with ciprofloxacin against multidrug-resistant Pseudomonas aeruginosa strains. Chemotherapy 2003;49: 294-7.
5. Giamarellou H. Aminoglycoside plus b-lactams against Gram-negative organisms. Evaluation of in vitro synergy and chemical interactions. American Journal of Medicine 1986;80:126-34.
6. Louie A, Grasso C, Bahniuk N, Van Scoy B, Brown DL, Kulawy R, et al. The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression. Antimicrobial Agents and Chemotherapy 2010;54:2646-54.
7. Song W, Woo HJ, Kim JS, Lee KM. In vitro activity of b-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa. International Journal of Antimicrobial Agents 2003;21:8-12.
8. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically; approved standard. 8th ed. Document M07-A8. Wayne, PA: CLSI; 2009.
9. Sanbongi Y, Shimizu A, Suzuki T, Nagaso H, Ida T, Maebashi K, et al. Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan. Microbiology and Immunology 2009;53:361-7.
10. Shibata N, Doi Y, Yamane K, Yagi T, Kurokawa H, Shibayama K, et al. PCR typing of genetic determinants for metallo-b-lactamases and integrases carried by Gram-negative bacteria isolated in Japan, with focus on the class 3 integron. Journal of Clinical Microbiology 2003;41:5407-13.
11. Jalal S, Wretlind B. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa. Microbial Drug Resistance 1998;4:257-61.
12. Vos P, Hogers R, Bleeker M, Reijans M, Lee T, Hornes M, et al. AFLP: a new technique for DNA fingerprinting. Nucleic Acids Research 1995;23:4407-14.
13. Tateda K, Ishii Y, Matsumoto T, Yamaguchi K. 'Break-point Checkerboard Plate' for screening of appropriate antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa. Scandinavian Journal of Infectious Diseases 2006;38:268-72.
14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. Document M100-S22. Wayne, PA: CLSI; 2012.
15. Watanabe M, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1991;35:147-51.
16. Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Kasai A, Mizuguchi Y, Araake M, et al. Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. Journal of Clinical Microbiology 2007;45:979-89.
17. Laraki N, Franceschini N, Rossolini GEN, Santucci P, Meunier C, de Pauw E, et al. Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-b-lactamase IMP-1 produced by Escherichia coli. Antimicrobial Agents and Chemotherapy 1999;43:902-6.
18. Pool K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 2005;49:479-87.
19. Araoka H, Baba M, Takagi S, Matsuno N, Ishiwata K, Nakano N, et al. Monobactam and aminoglycoside combination therapy against metallo-b-lactamase- producing multidrug-resistant Pseudomonas aeruginosa screened using a 'break-point checkerboard plate'. Scandinavian Journal of Infectious Diseases 2010;42:231-3.
20. Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Fujino T, Kobayashi I, Morita K, et al. Multidrug-resistant Pseudomonas aeruginosa strain that caused an outbreak in a neurosurgery ward and its aac(60)-Iae gene cassette encoding a novel aminoglycoside acetyltransferase. Antimicrobial Agents and Chemotherapy 2005;49:3734-42.
21. Yamane K, Wachino J, Suzuki S, Shibata N, Kato H, Shibayama K, et al. 16S rRNA methylase-producing, Gram-negative pathogens, Japan. Emerging Infectious Diseases 2007;13:642-6.
22. Giamarellos-Bourboulis EJ, Sambatakou H, Galani I, Giamarellou H. In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa. Journal of Chemotherapy 2003;15:235-8.